Triparna Sen

7.3k total citations · 5 hit papers
68 papers, 3.5k citations indexed

About

Triparna Sen is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Triparna Sen has authored 68 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 33 papers in Molecular Biology and 22 papers in Cancer Research. Recurrent topics in Triparna Sen's work include Lung Cancer Research Studies (35 papers), Peptidase Inhibition and Analysis (13 papers) and Protease and Inhibitor Mechanisms (12 papers). Triparna Sen is often cited by papers focused on Lung Cancer Research Studies (35 papers), Peptidase Inhibition and Analysis (13 papers) and Protease and Inhibitor Mechanisms (12 papers). Triparna Sen collaborates with scholars based in United States, India and Japan. Triparna Sen's co-authors include Charles M. Rudin, Amitava Chatterjee, Fathema Uddin, Lauren A. Byers, Anindita Dutta, Jing Wang, John V. Heymach, Àlvaro Quintanal-Villalonga, Lerong Li and Joseph M. Chan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Triparna Sen

61 papers receiving 3.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer

2019 616 citations Triparna Sen, B. Leticia Rodriguez et al. Cancer Discovery profile →
CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future

2020 354 citations Fathema Uddin, Charles M. Rudin et al. profile →
Lineage plasticity in cancer: a shared pathway of therapeutic resistance

2020 310 citations Àlvaro Quintanal-Villalonga, Joseph M. Chan et al. Nature Reviews Clinical Oncology profile →
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization

2020 301 citations Jacklynn V. Egger, Jennifer L. Sauter et al. profile →
Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis

2023 119 citations Utsav Sen, Charles Coleman et al. Trends in cancer profile →

Peers

Countries citing papers authored by Triparna Sen

Since Specialization

Citations

This map shows the geographic impact of Triparna Sen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Triparna Sen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Triparna Sen more than expected).

Fields of papers citing papers by Triparna Sen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Triparna Sen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Triparna Sen. The network helps show where Triparna Sen may publish in the future.

Co-authorship network of co-authors of Triparna Sen

This figure shows the co-authorship network connecting the top 25 collaborators of Triparna Sen. A scholar is included among the top collaborators of Triparna Sen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Triparna Sen. Triparna Sen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Histologic Transformation in Cancer: The Path for Clinical Translation 2025 ·Cancer Discovery ·Ioannis Vathiotis, Avisek Banerjee, Utsav Sen, Felix Carl Saalfeld, Debdatta Halder, Andriani Charpidou, K. Syrigos, Hidehito Horinouchi, Ashutosh Tewari, Mark A. Dawson, Martin Wermke, Triparna Sen	0
2	SCD1 Inhibition Blocks the AKT–NRF2–SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma 2025 ·Cancer Research ·Utsav Sen, Charles Coleman, Nishant Gandhi, (unknown), Deniz Demircioğlu, Andrew Elliott, Ari M. Vanderwalde, Omar Hayatt, Elisa de Stanchina, Balázs Halmos, C. Patrick, Mirela Berisa, Dan Hasson, Triparna Sen	11
3	Pulmonary neuroendocrine neoplasms: the molecular landscape, therapeutic challenges, and diagnosis and management strategies 2025 ·The Lancet Oncology ·Triparna Sen, (unknown), Virginia Corbett, Sonam Puri, Utsav Sen, Theresa A. Boyle, Philip C. Mack, Fred R. Hirsch, Raid Aljumaily, Abdul Rafeh Naqash, Vineeth Sukrithan, Nagla Abdel Karim	8
4	KRAS mutated NSCLC: past, present, and future directions in a rapidly evolving landscape 2025 ·The Oncologist ·A. S. Frisch, Éric Martin, So Yeon Kim, Jonathan W. Riess, Triparna Sen, Nagla Abdel Karim	0
5	Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer 2024 ·Nature Reviews Clinical Oncology ·Triparna Sen, Nobuyuki Takahashi, (unknown), Naoko Takebe, Amin H. Nassar, Nagla Abdel Karim, Sonam Puri, Abdul Rafeh Naqash	43
6	Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer 2024 ·Cell Reports Medicine ·(unknown), Utsav Sen, (unknown), (unknown), Charles Coleman, (unknown), (unknown), (unknown), (unknown), (unknown), Elisa de Stanchina, Misty Dawn Shields, Lewis E. Tomalin, Deniz Demircioğlu, Theresa A. Boyle, Anna S. Tocheva, Dan Hasson, Triparna Sen	4
7	De Novo and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways 2023 ·Clinical Cancer Research ·(unknown), Charles Coleman, Parvathy Manoj, Deniz Demircioğlu, Nisargbhai Shah, Elisa de Stanchina, Charles M. Rudin, Dan Hasson, Triparna Sen	17
8	Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis breakdown → 2023 ·Trends in cancer ·Utsav Sen, Charles Coleman, Triparna Sen	119
9	WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC 2022 ·Cell Reports ·Hirokazu Taniguchi, Rebecca Caeser, Shweta S. Chavan, Yingqian A. Zhan, Andrew Chow, Parvathy Manoj, Fathema Uddin, Hidenori Kitai, Rui Qu, Omar Hayatt, Nisargbhai Shah, (unknown), Viola Allaj, Evelyn M. Nguyen, Joseph M. Chan, Adam O. Michel, Hiroshi Mukae, Elisa de Stanchina, Charles M. Rudin, Triparna Sen	81
10	Pan‐HER inhibitors overcome lorlatinib resistance caused by NRG1/HER3 activation in ALK‐rearranged lung cancer 2022 ·Cancer Science ·Hirokazu Taniguchi, (unknown), (unknown), Tadaaki Yamada, (unknown), (unknown), (unknown), Shinnosuke Takemoto, Hiroyuki Yamaguchi, Triparna Sen, Seiji Yano, Hiroshi Mukae	8
11	7MO WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in small cell lung cancer 2022 ·Annals of Oncology ·Triparna Sen	1
12	Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library 2022 ·Genome Medicine ·Michael Offin, Jennifer L. Sauter, Sam E. Tischfield, Jacklynn V. Egger, Shweta S. Chavan, Nisargbhai Shah, Parvathy Manoj, Katia Ventura, Viola Allaj, Elisa de Stanchina, William D. Travis, Marc Ladanyi, Andreas Rimner, Valerie W. Rusch, Prasad S. Adusumilli, John T. Poirier, Marjorie G. Zauderer, Charles M. Rudin, Triparna Sen	3
13	An optimized NGS sample preparation protocol for in vitro CRISPR screens 2021 ·STAR Protocols ·Corrin A. Wohlhieter, Fathema Uddin, Àlvaro Quintanal-Villalonga, John T. Poirier, Triparna Sen, Charles M. Rudin	2
14	The MEK5–ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer 2020 ·Cancer Research ·Sandra Cristea, Garry L. Coles, Daniel Hornburg, Maya Gershkovitz, Julia Arand, Siqi Cao, Triparna Sen, Stuart C. Williamson, (unknown), Alexandros P. Drainas, (unknown), Laurent Le Cam, Lauren A. Byers, M Snyder, Kévin Contrepois, Julien Sage	52
15	Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer breakdown → 2019 ·Cancer Discovery ·Triparna Sen, B. Leticia Rodriguez, Limo Chen, Carminia Maria Della Corte, Naoto Morikawa, Junya Fujimoto, Sandra Cristea, Thuyen Nguyen, Lixia Diao, Lerong Li, You-Hong Fan, Yongbin Yang, Jing Wang, Bonnie S. Glisson, Ignacio I. Wistuba, Julien Sage, John V. Heymach, Don L. Gibbons, Lauren A. Byers	616
16	Differential Sensitivity Analysis for Resistant Malignancies (DISARM) Identifies Common Candidate Therapies across Platinum-Resistant Cancers 2018 ·Clinical Cancer Research ·Carl M. Gay, Pan Tong, Robert J. Cardnell, Triparna Sen, (unknown), Jun Ma, (unknown), Faye M. Johnson, Chris Wakefield, John V. Heymach, Jing Wang, Lauren A. Byers	12
17	Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small-Cell Lung Cancer 2017 ·Clinical Cancer Research ·Triparna Sen, Pan Tong, Lixia Diao, Lerong Li, You-Hong Fan, (unknown), John V. Heymach, Jing Wang, Lauren A. Byers	101
18	A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes 2017 ·Molecular Therapy — Nucleic Acids ·(unknown), (unknown), Triparna Sen, Mohammad Shadab, Indranil Banerjee, (unknown), Nahid Ali	49
19	Genome Wide Expression Profiling during Spinal Cord Regeneration Identifies Comprehensive Cellular Responses in Zebrafish 2014 ·PLoS ONE ·Subhra Prakash Hui, Dhriti Sengupta, (unknown), Triparna Sen, Sudip Kundu, Sinnakaruppan Mathavan, Sukla Ghosh	71
20	Laminin induces matrix metalloproteinase-9 expression and activation in human cervical cancer cell line (SiHa) 2010 ·Journal of Cancer Research and Clinical Oncology ·Gargi Maity, Triparna Sen, Amitava Chatterjee	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact